{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T23:47:03Z","timestamp":1794700023682,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1023\/a:1026616832119","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T12:29:30Z","timestamp":1068121770000},"page":"986-990","source":"Crossref","is-referenced-by-count":61,"title":["Bowman-Birk Inhibitor Concentrate Reduces Colon Inflammation in Mice with Dextran Sulfate Sodium-Induced Ulcerative Colitis"],"prefix":"10.1007","volume":"44","author":[{"given":"Jeffrey H.","family":"Ware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Steven","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Newberne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann R.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"296010_CR1","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1073\/pnas.82.16.5395","volume":"82","author":"J Yavelow","year":"1985","unstructured":"Yavelow J, Collins M, Birk Y, Troll W, Kennedy AR: Nanomolar concentrations of Bowman-Birk soybean protease inhibitors suppress X-ray induced transformation in vitro. Proc Natl Acad Sci USA 82:5395\u20135399, 1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"296010_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4615-2882-1_2","volume-title":"Protease Inhibitors as Cancer Chemopreventive Agents","author":"AR Kennedy","year":"1993","unstructured":"Kennedy AR: Anticarcinogenic activity of protease inhibitors: Overview. In Protease Inhibitors as Cancer Chemopreventive Agents. W Troll, AR Kennedy (eds). New York, Plenum Press, 1993, pp 9\u201364"},{"key":"296010_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/01635589309514259","volume":"19","author":"AR Kennedy","year":"1993","unstructured":"Kennedy AR, Szuhaj BF, Newberne PM, Billings PC: Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr Cancer 19:281\u2013302, 1993","journal-title":"Nutr Cancer"},{"key":"296010_CR4","first-page":"1437","volume":"58","author":"NI Larionova","year":"1993","unstructured":"Larionova NI, Gladysheva IP, Tikhonova TV, Kazanskaia NF: Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor. Biochemistry (Moscow) 58:1437\u20131444, 1993","journal-title":"Biochemistry"},{"key":"296010_CR5","first-page":"1295","volume":"59","author":"TV Tikhonova","year":"1994","unstructured":"Tikhonova TV, Gladysheva IP, Kazanshaya NF, Larionova NI: Hydrolysis of elastin by human leukocyte elastase and cathepsin G: Inhibition by Bowman Birk type inhibitor. Biochemistry (Moscow) 59:1295\u20131299, 1994","journal-title":"Biochemistry"},{"issue":"4","key":"296010_CR6","first-page":"513","volume":"59","author":"IP Gladysheva","year":"1994","unstructured":"Gladysheva IP, Larionova NI, Gladysheva DP, Tikhonova TV, Kazanskaia NF: The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G. Biochemistry (Moscow) 59(4):513\u2013518, 1994","journal-title":"Biochemistry"},{"key":"296010_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/abbi.1997.0182","volume":"344","author":"JH Ware","year":"1997","unstructured":"Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR: Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch Biochem Biophys 344:133\u2013138, 1997","journal-title":"Arch Biochem Biophys"},{"key":"296010_CR8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/carcin\/8.9.1207","volume":"8","author":"K Frenkel","year":"1987","unstructured":"Frenkel K, Chrazan K, Ryan CA, Wiesner R, Troll W: Chymotrypsin-specific protease inhibitors decrease H2O2 formation by activated human polymorphonuclear leukocytes. Carcinogenesis 8:1207\u20131212, 1987","journal-title":"Carcinogenesis"},{"key":"296010_CR9","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199109263251306","volume":"325","author":"DK Podolsky","year":"1991","unstructured":"Podolsky DK: Inflammatory bowel disease. N Engl J Med 325:928-937, 1008\u20131016, 1991","journal-title":"N Engl J Med"},{"key":"296010_CR10","first-page":"1403","volume-title":"Harrison's Principles of Internal Medicine","author":"RM Glickman","year":"1994","unstructured":"Glickman RM: Inflammatory Bowel disease: Ulcerative colitis and Crohn's disease. In Harrison's Principles of Internal Medicine. KJ Isselbacher, et al (eds). New York, McGraw-Hill, 1994, pp 1403-1417"},{"key":"296010_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365528708991857","volume":"22","author":"M Bohe","year":"1987","unstructured":"Bohe M: Pancreatic and granulocytic endoproteases in faecal extracts from patients with active ulcerative colitis. Scand J Gastroenterol 22:59\u201364, 1987","journal-title":"Scand J Gastroenterol"},{"key":"296010_CR12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/00365528609003106","volume":"21","author":"M Bohe","year":"1986","unstructured":"Bohe M, Genell S, Ohlsson K: Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease. Scand J Gastroenterol 21:598\u2013604, 1986","journal-title":"Scand J Gastroenterol"},{"key":"296010_CR13","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1023\/A:1018887832465","volume":"42","author":"JV Hawkins","year":"1996","unstructured":"Hawkins JV, Emmel EL, Feuer JJ, Nedelman MA, Harvey CJ, Klein HJ, Rozmiarek J, Kennedy AR, Lichtenstein GR, Billings PC: Protease activity in a hapten-induced model of ulcerative colitis in rats. Dig Dis Sci 42:1969\u20131980, 1996","journal-title":"Dig Dis Sci"},{"key":"296010_CR14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0025-7125(16)30108-0","volume":"78","author":"SB Hanauer","year":"1994","unstructured":"Hanauer SB, Baert F: Medical therapy of inflammatory bowel disease. Med Clin North Am 78:1413\u20131426, 1994","journal-title":"Med Clin North Am"},{"key":"296010_CR15","first-page":"47","volume-title":"Ulcerative Colitis","author":"KM Das","year":"1991","unstructured":"Das KM: Some current perspectives on the etiology and pathogenesis of ulcerative colitis. In Ulcerative Colitis.CA O'Morain (ed). Boca Raton, Florida, CRC Press, 1991, pp 47\u201354"},{"key":"296010_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0889-8553(21)00401-5","volume":"7","author":"MJ Wargovich","year":"1988","unstructured":"Wargovich MJ, Bauer AR, Hu PJ, Sumiyoshi H: Dietary factors and colorectal cancer. Gastroenterol Clin North Am 7:727\u2013745, 1988","journal-title":"Gastroenterol Clin North Am"},{"key":"296010_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ng0695-143","volume":"10","author":"U Rudolph","year":"1995","unstructured":"Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Boulay G, Bradley A, Birnbaumer L: Ulcerative colitis and adenocarcinoma of the colon in G-alpha-i2-deficient mice. Nature Genet 10:143\u2013150, 1995","journal-title":"Nature Genet"},{"key":"296010_CR18","first-page":"827","volume-title":"Robbins Pathologic Basis of Disease","author":"Y Dayal","year":"1989","unstructured":"Dayal Y, DeLellis RA: The gastrointestinal tract. In Robbins Pathologic Basis of Disease. RS Cotran, V Kumar, SL Robbins (eds). Philadelphia, WB Saunders, 1989, pp 827\u2013910"},{"key":"296010_CR19","first-page":"1","volume-title":"Ulcerative Colitis","author":"AS Pena","year":"1991","unstructured":"Pena AS, Shivanada S, Mayberry JF: Epidemiology of ulcerative colitis. In Ulcerative Colitis. CA O'Morain (ed). Boca Raton, Florida, CRC Press, 1991, pp 1\u20138"},{"key":"296010_CR20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2169\/internalmedicine.32.350","volume":"32","author":"S Senda","year":"1993","unstructured":"Senda S, Fujiyama Y, Bamba T, Hosoda S: Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor. Intern Med 32:350\u2013354, 1993","journal-title":"Intern Med"},{"key":"296010_CR21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0076-6879(76)45059-0","volume":"45","author":"Y Birk","year":"1975","unstructured":"Birk Y: Proteinase inhibitors from plant sources. Methods Enzymol 45:695\u2013751, 1975","journal-title":"Methods Enzymol"},{"key":"296010_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3011.1985.tb02155.x","volume":"25","author":"Y Birk","year":"1985","unstructured":"Birk Y: The Bowman-Birk inhibitor. Int J Peptide Protein Res 25:113\u2013131, 1985","journal-title":"Int J Peptide Protein Res"},{"key":"296010_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3835(92)90095-D","volume":"62","author":"PC Billings","year":"1992","unstructured":"Billings PC, Clair WHS, Maki PA, Kennedy AR: Distribution of the Bowman-Birk inhibitor in mice following oral administration. Cancer Lett 62:191\u2013197, 1992","journal-title":"Cancer Lett"},{"key":"296010_CR24","first-page":"2454","volume":"43","author":"J Yavelow","year":"1983","unstructured":"Yavelow J, Finlay TH, Kennedy AR, Troll W: Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res 43:2454\u20132459, 1983","journal-title":"Cancer Res"},{"key":"296010_CR25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0277-5379(91)90144-3","volume":"27","author":"PC Billings","year":"1991","unstructured":"Billings PC, Brandon DL, Habres JM: Internalization of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Eur J Cancer 27:903\u2013908, 1991","journal-title":"Eur J Cancer"},{"key":"296010_CR26","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper HS, Murthy SNS, Shah RS, Sedergran DJ: Clinicopathologic study of dextran sulfate sodium in experimental murine colitis. Lab Invest 69:238\u2013249, 1993","journal-title":"Lab Invest"},{"key":"296010_CR27","doi-asserted-by":"crossref","first-page":"A378","DOI":"10.1016\/0016-5085(94)90716-1","volume":"106","author":"HS Cooper","year":"1994","unstructured":"Cooper HS, Murthy SNS: Displasia in dextran sulfate sodium (DSS) experimental murine colitis.Gastroenterology 106:A378, 1994","journal-title":"Gastroenterology"},{"key":"296010_CR28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0016-5085(94)90803-6","volume":"107","author":"LA Dielman","year":"1994","unstructured":"Dielman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO: Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107:1643\u20131652, 1994","journal-title":"Gastroenterology"},{"key":"296010_CR29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","volume":"98","author":"I Okayasu","year":"1990","unstructured":"Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagake Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694\u2013702, 1990","journal-title":"Gastroenterology"},{"key":"296010_CR30","volume-title":"Biostatistical Analysis","author":"JH Zar","year":"1996","unstructured":"Zar JH: Biostatistical Analysis. Upper Saddle River, New Jersey, Prentice Hall, 1996"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1026616832119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1026616832119\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1026616832119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T03:10:06Z","timestamp":1752462606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1026616832119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["296010"],"URL":"https:\/\/doi.org\/10.1023\/a:1026616832119","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}